WuXi Biologics
WXXWY
#2248
Rank
$6.49 B
Marketcap
$3.08
Share price
-2.22%
Change (1 day)
-72.55%
Change (1 year)

P/E ratio for WuXi Biologics (WXXWY)

P/E ratio at the end of 2021: 91.0

According to WuXi Biologics's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 12.3902. At the end of 2021 the company had a P/E ratio of 91.0.

P/E ratio history for WuXi Biologics from 2017 to 2021

PE ratio at the end of each year

Year P/E ratio Change
202191.0-52.92%
202019376.09%
201911030.87%
201883.9-45%
2017152

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.